422 related articles for article (PubMed ID: 21760546)
1. Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children.
Grønbæk H; Lange A; Birkebæk NH; Holland-Fischer P; Solvig J; Hørlyck A; Kristensen K; Rittig S; Vilstrup H
J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):223-8. PubMed ID: 21760546
[TBL] [Abstract][Full Text] [Related]
2. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss.
Reinehr T; Roth CL
J Clin Endocrinol Metab; 2008 Nov; 93(11):4479-85. PubMed ID: 18728159
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis.
Reinehr T; Woelfle J; Wunsch R; Roth CL
J Clin Endocrinol Metab; 2012 Jun; 97(6):2143-50. PubMed ID: 22438225
[TBL] [Abstract][Full Text] [Related]
4. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
de Piano A; de Mello MT; Sanches Pde L; da Silva PL; Campos RM; Carnier J; Corgosinho F; Foschini D; Masquio DL; Tock L; Oyama LM; do Nascimento CM; Tufik S; Dâmaso AR
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160
[TBL] [Abstract][Full Text] [Related]
6. Liver steatosis in obese prepubertal children: a possible role of insulin resistance.
D'Adamo E; Impicciatore M; Capanna R; Loredana Marcovecchio M; Masuccio FG; Chiarelli F; Mohn AA
Obesity (Silver Spring); 2008 Mar; 16(3):677-83. PubMed ID: 18239582
[TBL] [Abstract][Full Text] [Related]
7. Reduced sCD36 following weight loss corresponds to improved insulin sensitivity, dyslipidemia and liver fat in obese children.
Knøsgaard L; Kazankov K; Birkebæk NH; Holland-Fischer P; Lange A; Solvig J; Hørlyck A; Kristensen K; Rittig S; Vilstrup H; Grønbæk H; Handberg A
Eur J Clin Nutr; 2016 Sep; 70(9):1073-7. PubMed ID: 27273071
[TBL] [Abstract][Full Text] [Related]
8. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.
Nobili V; Manco M; Devito R; Di Ciommo V; Comparcola D; Sartorelli MR; Piemonte F; Marcellini M; Angulo P
Hepatology; 2008 Jul; 48(1):119-28. PubMed ID: 18537181
[TBL] [Abstract][Full Text] [Related]
9. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents.
Ciba I; Widhalm K
Acta Paediatr; 2007 Jan; 96(1):109-12. PubMed ID: 17187615
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis in obese Chinese children.
Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
[TBL] [Abstract][Full Text] [Related]
11. Predictors of non-alcoholic fatty liver disease in obese children.
Sartorio A; Del Col A; Agosti F; Mazzilli G; Bellentani S; Tiribelli C; Bedogni G
Eur J Clin Nutr; 2007 Jul; 61(7):877-83. PubMed ID: 17151586
[TBL] [Abstract][Full Text] [Related]
12. [Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle].
Santomauro M; Paoli-Valeri M; Fernández M; Camacho N; Molina Z; Cicchetti R; Valeri L; Dávila de Campagnaro E; Arata-Bellabarba G
Endocrinol Nutr; 2012; 59(6):346-53. PubMed ID: 22717644
[TBL] [Abstract][Full Text] [Related]
13. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
Tilg H; Moschen A
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy.
Tock L; Prado WL; Caranti DA; Cristofalo DM; Lederman H; Fisberg M; Siqueira KO; Stella SG; Antunes HK; Cintra IP; Tufik S; de Mello MT; Dâmaso AR
Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1241-5. PubMed ID: 17099371
[TBL] [Abstract][Full Text] [Related]
15. Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy.
de Piano A; Tock L; Carnier J; Oyama LM; Oller do Nascimento CM; Martinz AC; Foschini D; Sanches PL; Ernandes RM; de Mello MT; Tufik S; Dâmaso AR
Metabolism; 2010 May; 59(5):613-9. PubMed ID: 19942238
[TBL] [Abstract][Full Text] [Related]
16. Abnormal liver function in children with metabolic syndrome from a UK-based obesity clinic.
Wei C; Ford A; Hunt L; Crowne EC; Shield JP
Arch Dis Child; 2011 Nov; 96(11):1003-7. PubMed ID: 21097793
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease.
de Piano A; Prado WL; Caranti DA; Siqueira KO; Stella SG; Lofrano M; Tock L; Cristofalo DM; Lederman H; Tufik S; de Mello MT; Dâmaso AR
J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):446-52. PubMed ID: 17414142
[TBL] [Abstract][Full Text] [Related]
18. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients.
Forlano R; Ippolito AM; Iacobellis A; Merla A; Valvano MR; Niro G; Annese V; Andriulli A
Gastrointest Endosc; 2010 May; 71(6):927-33. PubMed ID: 19863955
[TBL] [Abstract][Full Text] [Related]
19. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.
Reinehr T; Schmidt C; Toschke AM; Andler W
Arch Dis Child; 2009 Jun; 94(6):437-42. PubMed ID: 19224892
[TBL] [Abstract][Full Text] [Related]
20. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
